Summary: Belgium-based Sunrise, known for its chin sensor sleep diagnostic technology, is expanding in the US with telehealth solutions following its acquisition of Dreem Health, a California-based sleep clinic. The integration of Sunrise’s at-home sleep testing devices with Dreem Health’s network of providers and insurer partnerships aims to improve access to sleep care. Sunrise also appointed Laura Warnier as chief growth officer to lead its US expansion.
Key Takeaways:
- Strategic Acquisition: Sunrise acquired Dreem Health to combine its at-home sleep diagnostic technology with Dreem’s provider network and partnerships with major insurers.
- US Expansion Goals: People across California, Iowa, Maryland, Washington, and more can now access Sunrise’s sleep diagnostic and care devices through Dreem Health.
- Leadership for Growth: Laura Warnier, known for scaling startups, has joined Sunrise as Chief Growth Officer to oversee the company’s expansion in the U.S. market.
Beglium-based Sunrise, maker of a chin sensor that focuses on mandibular jaw movements for sleep analysis, announced plans to bring sleep care to the United States through telehealth services and online-based solutions.
The announcement follows the company’s acquisition of Dreem Health, a California-based sleep clinic that offers diagnosis and treatment options for sleep conditions. By pairing Sunrise’s diagnostic technology with Dreem Health’s partnerships with major insurers and Medicare, the company aims to democratize and accelerate access to sleep care. To date, Sunrise has received more than $35 million in capital from investors such as Amazon’s Alexa Fund, Kurma Partners, VIVES Partners, and others.
In addition to the Dreem Health acquisition, Sunrise has hired Laura Warnier as chief growth officer. Warnier brings a background in scaling startups, made evident by her tenure at EdTech Unicorn GoStudent, an online tutoring platform, which she scaled from 0 to $200 million and increased its employee count to 2,000 across Europe and America. Now at Sunrise, Warnier will oversee growth by building and managing the sales and marketing teams.
“As we build out our US presence, Sunrise is set to innovate the global sleep health market,” says Laurent Martinot, founder and CEO of Sunrise, in a release. “Since launching Sunrise in 2015, we’ve seen impressive growth driven by innovations in home sleep testing. However, the pace of change hasn’t been fast enough, and there’s still a major need for sleep health education. At Sunrise, we are committed to ensuring sleep disorders are properly recognized, diagnosed, and treated. With strategic moves like the acquisition of Dreem Health and the appointment of Laura Warnier as Chief Growth Officer, we’re strengthening our capabilities and establishing Sunrise as the global leader in sleep health.”
People across California, Iowa, Maryland, Washington, and more can now access Sunrise’s sleep diagnostic and care devices through Dreem Health. Sunrise is expanding into new states and will be available nationwide by 2025, according to a release from the company. Dreem Health’s licensed providers evaluate symptoms, diagnose a patient’s condition using the Sunrise at-home sleep test device, and either create a personalized treatment plan or refer the patient to a partner for further care.
Photo caption: Sunrise’s home sleep test
File photo
